Financials

  • Market Capitalization 481.79 M
  • Employee 485
  • Founded 2004
  • CEO Christian Henry
  • Website www.pacb.com
  • Headquarter Delaware, United States
  • FIGI BBG000QKXH20
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.1
Price to sales ratio
3.21

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2941
CLPT
ClearPoint Neuro Inc. - Common Stock
15.94 USD-2.63%+5.35%+10.62%+51.95%486.24 M USD
2943
NPCE
Neuropace, Inc. - Common Stock
14.13 USD-3.75%-0.07%-3.22%+33.55%485.00 M USD
2976
SGHT
Sight Sciences, Inc. - Common Stock
8.41 USD+0.48%+1.94%+58.68%+106.63%463.29 M USD
2982
MASS
908 Devices Inc. - Common Stock
11.10 USD+7.04%+6.63%+53.95%+75.91%458.80 M USD

Frequently asked questions about Pacific Biosciences of California, Inc.

What is the Pacific Biosciences of California, Inc. stock price today?

The current price of Pacific Biosciences of California, Inc. (PACB) is 1.55. Over the past 24 hours, the stock has changed by -0.64%. Follow the PACB chart for real-time price dynamics.

What is the stock ticker of Pacific Biosciences of California, Inc.?

Pacific Biosciences of California, Inc. trades under the ticker PACB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Pacific Biosciences of California, Inc. stock going up?

PACB has changed by +25.00% over the last week, +12.32% over the last month, and +16.54% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Pacific Biosciences of California, Inc.?

Pacific Biosciences of California, Inc. currently has a market capitalization of 481.79 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Pacific Biosciences of California, Inc. earnings last quarter?

Last quarter, Pacific Biosciences of California, Inc. reported earnings of -0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Pacific Biosciences of California, Inc. revenue for the last quarter?

Pacific Biosciences of California, Inc. reported quarterly revenue of 39.01 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Pacific Biosciences of California, Inc. net income for the last quarter?

Pacific Biosciences of California, Inc. reported net income of -44.74 M for the last quarter. The previous quarter showed -8.28 M, which means net income changed by -440.68%.

How many employees does Pacific Biosciences of California, Inc. have?

As of the latest available data, Pacific Biosciences of California, Inc. has 485 employees. Workforce size can provide additional context about the company's scale and operations.

What is Pacific Biosciences of California, Inc. EBITDA?

Pacific Biosciences of California, Inc. EBITDA is -42.11 M, and its EBITDA margin is -107.94%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Pacific Biosciences of California, Inc. stock?

You can buy Pacific Biosciences of California, Inc. (PACB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Pacific Biosciences of California, Inc. stock?

Investing in Pacific Biosciences of California, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PACB chart and related analysis on metatrader.com as part of your research.

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

News